Arsenic trioxide (As(2)O(3)) as a maintenance therapy for adult T cell leukemia/lymphoma

BACKGROUND: Adult T-cell leukemia-lymphoma (ATL) is an aggressive mature lymphoid proliferation associated with poor prognosis. Standard of care includes chemotherapy and/or the combination of zidovudine and interferon-alpha. However, most patients experience relapse less than 6 months after diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Marçais, Ambroise, Cook, Lucy, Witkover, Aviva, Asnafi, Vahid, Avettand-Fenoel, Véronique, Delarue, Richard, Cheminant, Morgane, Sibon, David, Frenzel, Laurent, de Thé, Hugues, Bangham, Charles R. M., Bazarbachi, Ali, Hermine, Olivier, Suarez, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085150/
https://www.ncbi.nlm.nih.gov/pubmed/32199462
http://dx.doi.org/10.1186/s12977-020-0513-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085150/
https://www.ncbi.nlm.nih.gov/pubmed/32199462
http://dx.doi.org/10.1186/s12977-020-0513-y

Ejemplares similares